Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression
Authors
Keywords
Muscle Quality, Myocyte, Sarcopenia, Steatosis
Journal
Clinical Gastroenterology and Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-01-31
DOI
10.1016/j.cgh.2022.01.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Muscle fat content is strongly associated with NASH: a longitudinal study in patients with morbid obesity
- (2021) Maxime Nachit et al. JOURNAL OF HEPATOLOGY
- Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
- (2020) Min Je Sung et al. Gut and Liver
- Myosteatosis in nonalcoholic fatty liver disease: An exploratory study
- (2020) Toon J.I. De Munck et al. Clinics and Research in Hepatology and Gastroenterology
- Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease
- (2020) Yun‐Cheng Hsieh et al. LIVER INTERNATIONAL
- Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
- (2020) Maxime Nachit et al. Journal of Cachexia Sarcopenia and Muscle
- Past, present and future perspectives in nonalcoholic fatty liver disease
- (2019) Arun J. Sanyal Nature Reviews Gastroenterology & Hepatology
- Relationship between nonalcoholic fatty liver disease and muscle quality as well as quantity evaluated by computed tomography
- (2019) Muhei Tanaka et al. LIVER INTERNATIONAL
- Urinary Levels of Titin-N Fragment, a Skeletal Muscle Damage Marker, are Increased in Subjects with Nonalcoholic Fatty Liver Disease
- (2019) Natsumi Oshida et al. Scientific Reports
- Relationship between relative skeletal muscle mass and non-alcoholic fatty liver disease: A 7-year longitudinal study
- (2018) Gyuri Kim et al. HEPATOLOGY
- Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant
- (2018) Aldo J. Montano-Loza et al. HEPATOLOGY
- Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease
- (2018) Donghee Kim et al. LIVER INTERNATIONAL
- Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis
- (2017) Rahima A. Bhanji et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
- (2017) Bo Kyung Koo et al. JOURNAL OF HEPATOLOGY
- A multicenter study to define sarcopenia in patients with end-stage liver disease
- (2017) Elizabeth J. Carey et al. LIVER TRANSPLANTATION
- Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation
- (2017) Yuhei Hamaguchi et al. TRANSPLANTATION
- Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease
- (2016) S. Petta et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Time to Abandon NASH?
- (2015) Jean-François Dufour HEPATOLOGY
- Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma
- (2015) Naoto Fujiwara et al. JOURNAL OF HEPATOLOGY
- Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis
- (2015) Aldo J. Montano-Loza et al. Journal of Cachexia Sarcopenia and Muscle
- Measurement of skeletal muscle radiation attenuation and basis of its biological variation
- (2014) J. Aubrey et al. Acta Physiologica
- Intramuscular Fat and Associations With Metabolic Risk Factors in the Framingham Heart Study
- (2013) Kate E. Therkelsen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle
- (2013) Yoichiro Kitajima et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Predictive value of ALT levels for NASH and advanced fibrosis
- (2013) Dawn M. Torres et al. Nature Reviews Gastroenterology & Hepatology
- Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
- (2010) A. J. Cruz-Jentoft et al. AGE AND AGEING
- Epidemiology of myosteatosis
- (2010) Iva Miljkovic et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
- (2010) Elizabeth M. Brunt et al. HEPATOLOGY
- Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
- (2009) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease
- (2009) Yoichiro Kitajima et al. JOURNAL OF GASTROENTEROLOGY
- Inflammation and Race and Gender Differences in Computerized Tomography-measured Adipose Depots
- (2009) Lydia E. Beasley et al. Obesity
- Muscular diacylglycerol metabolism and insulin resistance
- (2008) Silvie Timmers et al. PHYSIOLOGY & BEHAVIOR
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started